Search Results - "TSUGAWA, Koichiro"

Refine Results
  1. 1
  2. 2
  3. 3

    Subgroup analysis of Japanese patients in a Phase 3 study of atezolizumab in advanced triple-negative breast cancer (IMpassion130) by Iwata, Hiroji, Inoue, Kenichi, Kaneko, Koji, Ito, Yoshinori, Tsugawa, Koichiro, Hasegawa, Ayumi, Nakagawa, Shintaro, Kuratomi, Hiroyasu, Tamura, Kenji

    Published in Japanese journal of clinical oncology (27-12-2019)
    “…In the randomised Phase 3 IMpassion130 trial, atezolizumab combined with nab-paclitaxel (atezo + nab-P) in 902 patients with triple-negative breast cancer…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan by Iwatani, Tsuguo, Inoue, Eisuke, Tsugawa, Koichiro

    Published in BMJ open (01-12-2021)
    “…IntroductionAlthough there is a lack of data on health-state utility values (HSUVs) for calculating quality-adjusted life-years in Japan, cost–utility analysis…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Grading System to Categorize Breast MRI in BI-RADS 5th Edition: A Multivariate Study of Breast Mass Descriptors in Terms of Probability of Malignancy by Fujiwara, Keishi, Yamada, Takayuki, Kanemaki, Yoshihide, Okamoto, Satoko, Kojima, Yasuyuki, Tsugawa, Koichiro, Nakajima, Yasuo

    Published in American journal of roentgenology (1976) (01-03-2018)
    “…The purpose of this study is to analyze the association between the probability of malignancy and breast mass descriptors in the BI-RADS 5th edition and to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Changes in Health State Utility Values in Japanese Patients with End-Stage Breast Cancer by Iwatani, Tsuguo, Noto, Shinichi, Tsugawa, Koichiro

    Published in Current oncology (Toronto) (18-10-2021)
    “…We aimed to determine the dynamic trends in health state utility values (HSUVs) in patients with end-stage breast cancer. We selected 181 patients comprising…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition by Nagasawa, Satoi, Sedukhina, Anna S, Nakagawa, Yuko, Maeda, Ichiro, Kubota, Manabu, Ohnuma, Shigeko, Tsugawa, Koichiro, Ohta, Tomohiko, Roche-Molina, Marta, Bernal, Juan A, Narváez, Ana J, Jeyasekharan, Anand D, Sato, Ko

    Published in PloS one (13-02-2015)
    “…LSD1, a lysine-specific histone demethylase, is overexpressed in several types of cancers and linked to poor outcomes. In breast cancer, the significance of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Semibulk RNA-seq analysis as a convenient method for measuring gene expression statuses in a local cellular environment by Muto, Kyoko, Tsuchiya, Issei, Kim, Soo Hyeon, Nagasawa, Satoi, Takishita, Mariko, Tsugawa, Koichiro, Saito, Hiroaki, Komazaki, Yusuke, Torii, Toru, Fujii, Teruo, Suzuki, Yutaka, Suzuki, Ayako, Seki, Masahide

    Published in Scientific reports (12-09-2022)
    “…When biologically interpretation of the data obtained from the single-cell RNA sequencing (scRNA-seq) analysis is attempted, additional information on the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Comparison of diagnostic precision for bone metastasis of primary breast cancer between BONENAVI version 1 and BONENAVI version 2 by Okada, Yukinori, Matsushita, Shoichiro, Nakajima, Yasuo, Yamaguchi, Keiichiro, Okuda, Itsuko, Kojima, Yasuyuki, Tsugawa, Koichiro

    Published in Nuclear medicine communications (01-11-2019)
    “…OBJECTIVEThe aim of this study was to compare the diagnostic precision of bone scintigraphy with BONENAVI version 1 and BONENAVI version 2 in bone metastasis…”
    Get full text
    Journal Article